About: http://webisa.webdatacommons.org/226232547

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	With over 40% of the projects of large pharma companies in non-oncology areas, there is clearly a need to address the arising challenges such as resistance, specificity, off-target effects and efficacy.
http://www.w3.org/ns/prov#wasQuotedFrom	discoveryontarget.com